Infosys acquire Optimum Healthcare IT for $465 million to expand its health IT services, pending regulatory approval in early ...

Aurobindo Pharma announced that its subsidiary, CuraTeQ Biologics, has entered into a marketing and distribution agreement with STADA Arzneimittel AG. STADA will commercialize two EMA-approved ...

RadiantInsights.com include new market research report "INFY – Infosys Solar Power Park – Karnataka – Construction Project Profile" to its huge collection of research reports. The "INFY – Infosys ...

Infosys will acquire Optimum Healthcare IT through its subsidiary, gaining 100 percent ownership for up to 465 million ...

Healthcare providers are under pressure to improve efficiency while managing costs—opening the door for automation, data ...

Narrow-moat Infosys INFY reported first-quarter earnings below our expectations. Management offered a grimmer outlook for 2024 revenue growth, citing clients’ revision of discretionary spending and ...

BENGALURU: Infosys forecast one of its weakest revenue guidance ranges, between 0% and 3% for 2025-26, mainly due to macroeconomic uncertainties and tariff-related concerns. According to the company, ...

Gov. Roy Cooper, left, and Infosys president Ravi Kumar announced in 2017 that the tech expected to create 2,000 jobs in the Triangle. It acknowledged Tuesday that it would not meet that goal. Chris ...

BENGALURU: Infosys filed a counterclaim against Cognizant in a US court, alleging that its rival Cognizant and its CEO, Ravi Kumar, engaged in anticompetitive practices to stifle competition and ...

Infosys demand remains steady despite global uncertainty, with a $4.8 billion deal pipeline and rising AI revenues giving ...